Clinlogix is renowned as a Center of Excellence that offers outstanding consultancy and research services, specializing in metabolic disorders such as diabetes, obesity, dyslipidemia, artherosclerosis, and cardiovascular complications.
Having performed studies at the highest scientific level, we have gained a solid scientific expertise. We have completed more than 70 phase I-IV diabetes studies involving every clinically relevant diabetes drug class (Inhaled Insulin, Insulin Analogues, Long-acting Insulin, DPPIV Inhibitors, PPAR Agonists), and an extensive array of medical devices (BGMs, CGMS, Noninvasive Glucose Monitoring, Heating device, Usability studies). In addition, more than 20 studies covering the related therapeutic areas, mentioned above, have been completed.
Being involved in state-of-the-art research, we helped pioneer preventative compounds and treatment patterns.
Being located in key geographic regions of the world, we understand the local differences and working practices of investigators and regulators throughout the global scientific community. This working knowledge and regulatory intelligence saves time and money and helps our clients to efficiently move from bench to bedside.